Safety and preclinical efficacy of aerosol pioglitazone on lung adenoma prevention in A/J mice

Pioglitazone is a PPARγ agonist commonly prescribed for the clinical treatment of diabetes. We sought to expand its use to lung cancer prevention in a benzo[a]pyrene (B[a]P) mouse model with direct lung delivery via inhalation. Initially we conducted inhalational toxicity experiments with 0, 15, 50,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Prev Res (Phila)
Huvudupphovsmän: Seabloom, Donna E., Galbraith, Arthur R., Haynes, Anna M., Antonides, Jennifer D., Wuertz, Beverly R., Miller, Wendy A., Miller, Kimberly A., Steele, Vernon E., Suen, Chen S., O’Sullivan, M. Gerard, Ondrey, Frank G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5687250/
https://ncbi.nlm.nih.gov/pubmed/27993834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-16-0174
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk